Greenwich Lifesciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Greenwich Lifesciences Stock Summary

Greenwich Lifesciences competes with Reviva Pharmaceuticals, Immutep, Anavex Life, Virpax Pharmaceuticals, and Acurx Pharmaceuticals. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Greenwich Lifesciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Greenwich Lifesciences Key Financial Ratios

Greenwich Lifesciences Key Balance Sheet Accounts

Greenwich Lifesciences Key Cash Accounts

Greenwich Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Greenwich Lifesciences's current stock value. Our valuation model uses many indicators to compare Greenwich Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Greenwich Lifesciences competition to find correlations between indicators driving Greenwich Lifesciences's intrinsic value. More Info.Greenwich Lifesciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Greenwich Lifesciences' Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Greenwich Lifesciences' earnings, one of the primary drivers of an investment's value.

Greenwich Lifesciences Systematic Risk

Today, most investors in Greenwich Lifesciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Greenwich Lifesciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Greenwich Lifesciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Greenwich Lifesciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Greenwich Lifesciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Greenwich Lifesciences based on widely used predictive technical indicators. In general, we focus on analyzing Greenwich Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Greenwich Lifesciences's daily price indicators and compare them against related drivers.

When running Greenwich Lifesciences' price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.